Cogent Biosciences Inc

NASDAQ:COGT   3:59:43 PM EDT
8.33
+0.13 (+1.58%)
Earnings Announcements

Cogent Biosciences Reports Qtrly Loss Pe Share $6.06

Published: 03/16/2021 11:13 GMT
Cogent Biosciences Inc (COGT) - Cogent Biosciences Reports Fourth Quarter 2020 and Full Year 2020 Financial Results.
Qtrly Loss per Share $6.06.
Q4 Earnings per Share View $-0.51 -- Refinitiv Ibes Data (analyst estimates).
Ended Q4 2020 With $242.2 Million in Cash, Funding Operations Into 2024.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.36

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.35

More details on our Analysts Page.